Chou Associates Management
13F Holdings and Portfolio Analysis
Francis Chou 2018 Q3 13F holdings, quarterly changes, portfolio value trend and position weight distribution.
Chou Associates Management Overview
Chou Associates Management held 23 stocks in 2018 Q3, with total market value around $0.30B.
Chou Associates Management's top five holdings in 2018 Q3: RESOLUTE FST PRODS INC 22.28%, BERKSHIRE HATHAWAY INC CL A(BRK.A) 16.12%, BAUSCH HEALTH COS INC COMMON STOCK(BHC) 14.22%, ENDO INTL PLC 8.93%, Wells Fargo & Company(WFC) 7.67%.
- Portfolio Value
- $0.30B
- Current Holdings
- 23 stocks
- New / Increased
- 4 / 2
- Reduced / Exited
- 8 / 6
Current Holdings
| 1 | RESOLUTE FST PRODS INCCUSIP 76117W109 | 0.07 | 22.28% | 5.12 +8.47% | $12.95 | - | $12.17 | +0.40 | 5.50 | +$0.00B+6.39% | Increased |
| 2 | BERKSHIRE HATHAWAY INC CL ABRK.A | 0.05 | 16.12% | 0.00 - | $320000.00 | $705400.23 +120.44% | $168600.00 | 0.00 | 5.50 | +$0.08B+318.39% | Held |
| 3 | BAUSCH HEALTH COS INC COMMON STOCKBHC | 0.04 | 14.22% | 1.65 | $25.67 | - | $25.67 | +1.65 | 0.25 | $0.00B0.00% | New |
| 4 | ENDO INTL PLCCUSIP G30401106 | 0.03 | 8.93% | 1.58 +79.55% | $16.83 | - | $11.03 | +0.70 | 1.75 | +$0.01B+52.60% | Increased |
| 5 | Wells Fargo & CompanyWFC | 0.02 | 7.67% | 0.43 | $52.56 | $84.56 +60.88% | $52.56 | +0.43 | 0.25 | +$0.01B+60.88% | New |
| 6 | SanofiSNY | 0.02 | 5.40% | 0.36 -12.20% | $44.67 | $49.22 +10.19% | $51.51 | -0.05 | 5.50 | -$0.00B-4.45% | Reduced |
| 7 | JPMorgan Chase & Co.JPM | 0.01 | 4.14% | 0.11 | $112.84 | $297.41 +163.56% | $112.84 | +0.11 | 0.25 | +$0.02B+163.56% | New |
| 8 | The Goldman Sachs Group, Inc.GS | 0.01 | 3.77% | 0.05 -33.33% | $224.24 | $751.53 +235.15% | $151.25 | -0.03 | 5.50 | +$0.03B+396.87% | Reduced |
| 9 | MBIA INC COMMBI | 0.01 | 3.44% | 0.96 -11.35% | $10.69 | - | $13.31 | -0.12 | 5.50 | -$0.00B-19.68% | Reduced |
| 10 | DaVita Inc.DVA | 0.01 | 3.39% | 0.14 - | $71.63 | $195.06 +172.33% | $69.44 | 0.00 | 0.50 | +$0.02B+180.91% | Held |
| 11 | Citigroup Inc.C | 0.01 | 3.13% | 0.13 -38.10% | $71.74 | $97.52 +35.94% | $47.97 | -0.08 | 5.50 | +$0.01B+103.29% | Reduced |
| 12 | BLACKBERRY LTD COMBB | 0.01 | 2.01% | 0.53 - | $11.32 | - | $7.89 | 0.00 | 5.25 | +$0.00B+43.40% | Held |
| 13 | SEARS HOMETOWN & OUTLET STORCUSIP 812362101 | 0.00 | 1.26% | 1.31 -0.78% | $2.85 | - | $11.59 | -0.01 | 4.25 | -$0.01B-75.41% | Reduced |
| 14 | Bank of America CorporationBAC | 0.00 | 0.92% | 0.09 | $29.46 | $51.42 +74.55% | $29.46 | +0.09 | 0.25 | +$0.00B+74.55% | New |
| 15 | COMPUCREDIT HLDGS CORPCUSIP 20478NAD2 | 0.00 | 0.86% | 4.80 -9.43% | $0.53 | - | $0.44 | -0.50 | 2.50 | +$0.00B+21.36% | Reduced |
| 16 | SPIRIT AIRLINES INC COMCUSIP 848577102 | 0.00 | 0.79% | 0.05 - | $46.98 | - | $36.36 | 0.00 | 0.50 | +$0.00B+29.21% | Held |
| 17 | POSCO HOLDINGS INC -SPON ADRPKX | 0.00 | 0.47% | 0.02 - | $66.00 | - | $35.05 | 0.00 | 3.25 | +$0.00B+88.32% | Held |
| 18 | China Yuchai International LimitedCYD | 0.00 | 0.43% | 0.07 - | $17.27 | $34.95 +102.37% | $5.87 | 0.00 | 5.50 | +$0.00B+495.02% | Held |
| 19 | ALLEGIANT TRAVEL COCUSIP 01748X102 | 0.00 | 0.18% | 0.00 - | $126.71 | - | $138.99 | 0.00 | 0.50 | -$0.00B-8.83% | Held |
| 20 | SEARS HLDGS CORPCUSIP 812350106 | 0.00 | 0.16% | 0.51 -55.34% | $0.97 | - | $26.53 | -0.63 | 5.50 | -$0.01B-96.35% | Reduced |
| 21 | ASCENT CAP GROUP INCCUSIP 043632108 | 0.00 | 0.16% | 0.27 -12.42% | $1.77 | - | $15.39 | -0.04 | 2.50 | -$0.00B-88.51% | Reduced |
| 22 | RYANAIR HOLDINGS PLC SPONSORED ADSRYAAY | 0.00 | 0.15% | 0.00 - | $95.96 | - | $86.46 | 0.00 | 3.00 | +$0.00B+10.99% | Held |
| 23 | Teva Pharmaceutical Industries LimitedTEVA | 0.00 | 0.11% | 0.01 - | $21.53 | $20.11 -6.61% | $32.81 | 0.00 | 1.75 | -$0.00B-38.71% | Held |
Showing 1-23 of 23
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis is an estimate and can differ materially from the actual cost, especially in edge cases.
Cost basis estimate: from the latest uninterrupted holding period, new or increased shares are added to the cost pool at the report price; reductions remove shares at the then-average cost. Example: buy 100 shares at $10 in Q1 and add 50 shares at $16 in Q2, estimated cost basis is (100 x 10 + 50 x 16) / 150 = $12 per share.
Return shows estimated dollar return on top and percentage return below. It uses current price when available, otherwise report price.
Exited Holdings
Stocks no longer disclosed in the current 13F portfolio for 2018 Q3.
| 1 | VALEANT PHARMACEUTICALS INTLCUSIP 91911K102 | 1.65 | 2.50 | $43.69 | $23.24 | -$0.03B-46.80% |
| 2 | WELLS FARGO & CO NEWCUSIP 949746119 | 1.00 | 5.25 | $13.67 | $19.27 | +$0.01B+40.97% |
| 3 | JPMORGAN CHASE & COCUSIP 46634E114 | 0.17 | 3.75 | $20.81 | $63.43 | +$0.01B+204.82% |
| 4 | NOKIA OYJ COMMON STOCKNOK | 0.65 | 5.25 | $3.74 | $5.75 | +$0.00B+53.76% |
| 5 | BANK AMER CORPCUSIP 060505146 | 0.15 | 5.25 | $16.41 | $17.81 | +$0.00B+8.53% |
| 6 | OVERSTOCK COM INC DELCUSIP 690370101 | 0.01 | 5.25 | $56.40 | $33.68 | -$0.00B-40.28% |
Showing 1-6 of 6
Exited holdings are stocks disclosed in the previous report period but no longer disclosed in the current 13F portfolio.
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis uses the same weighted cost-pool method as current holdings. Estimated exit price uses the current report period weighted report price when available, otherwise the previous report price; it does not represent the actual sale price.
Exit return shows estimated dollar return on top and percentage return below.
Portfolio Visuals
Track portfolio value, position weights and Top 10 history.